Aprea Therapeutics, Inc.
Price Action
Technical Summary
WEAKENINGAprea Therapeutics, Inc. is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is weak (RS Rating: 24), showing significant lag compared to the market leaders. Earnings growth of 35% provides fundamental context to the price action. Investors should exercise caution due to high volatility (90% annualized), which requires wider risk management.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $0.77 | +2.86% | ABOVE |
| 50 SMA | $0.84 | -6.42% | BELOW |
| 100 SMA | $0.80 | -1.56% | BELOW |
| 150 SMA | $0.85 | -7.12% | BELOW |
| 200 SMA | $0.99 | -20.60% | BELOW |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is APRE in an uptrend right now?
APRE has a trend score of 1/4 based on Minervini's Stage Analysis. Currently showing broken structure - 1 of 4 trend criteria are met.
Is APRE overbought or oversold?
APRE's RSI (14) is 49. The stock is in neutral territory, neither overbought nor oversold.
Is APRE outperforming the market?
APRE has a Relative Strength (RS) Rating of 24 out of 99. APRE is currently lagging the broader market.
Where is APRE in its 52-week range?
APRE is trading at $0.79, which is 36% of its 52-week high ($2.22) and 14% above its 52-week low ($0.55).
How volatile is APRE?
APRE has a Beta of 1.20 and 52-week volatility of 90%. It's more volatile than the S&P 500 - expect bigger swings.